Compare Kraft Heinz Co (KHC) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kraft Heinz Co vs Sana Biotechnology Inc — how do they compare? Kraft Heinz Co trades at $25.76 (market cap $30.66B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Kraft Heinz Co is far larger — about 35.1× Sana Biotechnology Inc's market cap, and Kraft Heinz Co pays a 6.19% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| KHC | SANA | |
|---|---|---|
Market Cap | $30.66B | $873.84M |
Sector | Consumer Staples | Health |
52-Week High | $28.94 | $5.92 |
52-Week Low | $21.21 | $2.68 |
Enterprise Value | $47.71B | $848.03M |
Dividend Yield | 6.19% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kraft Heinz (KHC) trades at $25.79, down 0.35% on the day. The stock shows a bullish technical trend with moving averages supporting upside, though RSI levels suggest potential overbought conditions. Fundamentally, the company reported a net loss of $5.85 billion in 2025, driving negative profit margins, but has beaten EPS estimates for three consecutive quarters. Recent news highlights a strategic partnership with Disney aimed at brand revitalization.
The outlook remains cautious due to profitability challenges, offset by a high 6.4% dividend yield and undervaluation signals like a P/B of 0.73. Risks include sustained negative earnings and high debt levels. Analyst consensus is mixed, with a hold-heavy rating and a price target below the current price, indicating limited near-term upside potential.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
